Epithelial-Mesenchymal Transition gene database (dbEMT) Home
dbEMT
dbEMT 2.0
General information | Literature | Expression | lncRNA |Regulation | Mutation | Homolog | Interaction

Basic Information

From Entrez database: 6352

Gene ID

6352

Name

CCL5

Synonym

D17S136E|RANTES|SCYA5|SIS-delta|SISd|TCP228|eoCP;chemokine (C-C motif) ligand 5;CCL5;chemokine (C-C motif) ligand 5

Definition

C-C motif chemokine 5|T-cell specific protein p288|beta-chemokine RANTES|eosinophil chemotactic cytokine|regulated upon activation, normally T-expressed, and presumably secreted|small inducible cytokine subfamily A (Cys-Cys), member 5

Position

17q12

Gene Type

protein-coding

Pathways and Diseases

From KEGG database

Pathway

Chagas disease;KEGG PATHWAY;hsa05142

Pathway

Syndecan-4-mediated signaling events;PID Curated;200115

Pathway

Prion diseases;KEGG PATHWAY;hsa05020

Pathway

Validated targets of C-MYC transcriptional repression;PID Curated;200171

Pathway

Toll-like receptor signaling pathway;KEGG PATHWAY;hsa04620

Pathway

Signaling by GPCR;Reactome;REACT:14797

Pathway

NOD-like receptor signaling pathway;KEGG PATHWAY;hsa04621

Pathway

Chemokine signaling pathway;KEGG PATHWAY;hsa04062

Pathway

Epithelial cell signaling in Helicobacter pylori infection;KEGG PATHWAY;hsa05120

Pathway

Syndecan-1-mediated signaling events;PID Curated;200134

Pathway

Cytosolic DNA-sensing pathway;KEGG PATHWAY;hsa04623

Pathway

Inflammation mediated by chemokine and cytokine signaling pathway;PANTHER;P00031

Pathway

Chemokine receptors bind chemokines;PID Reactome;500406

Pathway

Cytokine-cytokine receptor interaction;KEGG PATHWAY;hsa04060

Disease

Lupus erythematosus;FunDO

Disease

atopy;GAD

Disease

Anemia;FunDO

Disease

allergic rhinitis;GAD

Disease

Hepatitis C, Chronic;GAD

Disease

kidney transplant;GAD

Disease

Alcoholic liver disease;FunDO

Disease

Lung cancer;FunDO

Disease

Hyperglycemia;FunDO

Disease

Melanoma;FunDO

Disease

Hepatitis C;FunDO

Disease

diabetes, type 2;GAD

Disease

Stomach cancer;FunDO

Disease

Endometriosis;FunDO

Disease

Bronchiolitis;FunDO

Disease

atherosclerosis, carotid myocardial infarct;GAD

Disease

hepatitis B;GAD

Disease

Dermatitis;FunDO

Disease

Prostate cancer;FunDO

Disease

Chronic rejection of renal transplant;FunDO

Disease

HTLV-I infection;FunDO

Disease

Infection;FunDO

Disease

HIV;GAD

Disease

Rheumatoid arthritis;FunDO

Disease

cardiovascular disease;GAD

Disease

Pulmonary fibrosis;FunDO

Disease

Leukemia;FunDO

Disease

Kidney Failure, Chronic;GAD

Disease

Asthma;GAD

Disease

sclerosis, systemic;GAD

Disease

INFECTION;GAD

Disease

nephropathy in other diseases;GAD

Disease

HIV-1 disease, rapid progression of;OMIM

Disease

Bronchial disease;FunDO

Disease

METABOLIC;GAD

Disease

Synovitis;FunDO

Disease

Diabetes mellitus;FunDO

Disease

Thrombocytopenia;FunDO

Disease

HIV-1 disease, delayed progression of;OMIM

Disease

Nasal Polyps;GAD

Disease

CARDIOVASCULAR;GAD

Disease

Multiple sclerosis;FunDO

Disease

Basal cell carcinoma;FunDO

Disease

Kidney failure;FunDO

Disease

Graves' disease;FunDO

Disease

Chronic obstructive airway disease;FunDO

Disease

IMMUNE;GAD

Disease

Hyperlipidemia;FunDO

Disease

Enteritis;FunDO

Disease

Influenza;FunDO

Disease

Lupus vulgaris;FunDO

Disease

Thyroid gland disease;FunDO

Disease

Infertility;FunDO

Disease

Asthma. atopy. atopic dermatitis;GAD

Disease

RENAL;GAD

Disease

Atherosclerosis;FunDO

External Links

Links to Entrez Gene

6352

Links to all GeneRIF Items

6352

Sequence Information

Nucleotide Sequence

>6352 : length: 1319
GCTGCAGAGGATTCCTGCAGAGGATCAAGACAGCACGTGGACCTCGCACAGCCTCTCCCA
CAGGTACCATGAAGGTCTCCGCGGCAGCCCTCGCTGTCATCCTCATTGCTACTGCCCTCT
GCGCTCCTGCATCTGCCTCCCCATATTCCTCGGACACCACACCCTGCTGCTTTGCCTACA
TTGCCCGCCCACTGCCCCGTGCCCACATCAAGGAGTATTTCTACACCAGTGGCAAGTGCT
CCAACCCAGCAGTCGTCCACAGGTCAAGGATGCCAAAGAGAGAGGGACAGCAAGTCTGGC
AGGATTTCCTGTATGACTCCCGGCTGAACAAGGGCAAGCTTTGTCACCCGAAAGAACCGC
CAAGTGTGTGCCAACCCAGAGAAGAAATGGGTTCGGGAGTACATCAACTCTTTGGAGATG
AGCTAGGATGGAGAGTCCTTGAACCTGAACTTACACAAATTTGCCTGTTTCTGCTTGCTC
TTGTCCTAGCTTGGGAGGCTTCCCCTCACTATCCTACCCCACCCGCTCCTTGAAGGGCCC
AGATTCTACCACACAGCAGCAGTTACAAAAACCTTCCCCAGGCTGGACGTGGTGGCTCAC
GCCTGTAATCCCAGCACTTTGGGAGGCCAAGGTGGGTGGATCACTTGAGGTCAGGAGTTC
GAGACCAGCCTGGCCAACATGATGAAACCCCATCTCTACTAAAAATACAAAAAATTAGCC
GGGCGTGGTAGCGGGCGCCTGTAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAGAATGGC
GTGAACCCGGGAGGCGGAGCTTGCAGTGAGCCGAGATCGCGCCACTGCACTCCAGCCTGG
GCGACAGAGCGAGACTCCGTCTCAAAAAAAAAAAAAAAAAAAAAAATACAAAAATTAGCC
GGGCGTGGTGGCCCACGCCTGTAATCCCAGCTACTCGGGAGGCTAAGGCAGGAAAATTGT
TTGAACCCAGGAGGTGGAGGCTGCAGTGAGCTGAGATTGTGCCACTTCACTCCAGCCTGG
GTGACAAAGTGAGACTCCGTCACAACAACAACAACAAAAAGCTTCCCCAACTAAAGCCTA
GAAGAGCTTCTGAGGCGCTGCTTTGTCAAAAGGAAGTCTCTAGGTTCTGAGCTCTGGCTT
TGCCTTGGCTTTGCCAGGGCTCTGTGACCAGGAAGGAAGTCAGCATGCCTCTAGAGGCAA
GGAGGGGAGGAACACTGCACTCTTAAGCTTCCGCCGTCTCAACCCCTCACAGGAGCTTAC
TGGCAAACATGAAAAATCGGCTTACCATTAAAGTTCTCAATGCAACCATAAAAAAAAAA



')